deltatrials
Terminated NA INTERVENTIONAL 1-arm NCT01981252

Peri-orbital and Peri-oral Wrinkle Reduction Trial

Evaluation of the Safety and Efficacy of the Ulthera® System for Wrinkle Reduction in the Peri-orbital and Peri-oral Regions

Sponsor: Ulthera, Inc

Updated 8 times since 2017 Last updated: Nov 21, 2017 Started: Oct 31, 2013 Primary completion: Aug 31, 2014 Completion: Aug 31, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Lack of efficacy.

A NA clinical study on Peri-oral Wrinkles and Peri-orbital Wrinkles, this trial is terminated or withdrawn. The trial is conducted by Ulthera, Inc and has accumulated 8 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Dec 2017 · 10 months · monthly snapshotTerminated~Dec 2017 – ~Feb 2018 · 2 months · monthly snapshotTerminated~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

8 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated NA

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated NA

  5. Feb 2018 — Jun 2018 [monthly]

    Terminated NA

Show 3 earlier versions
  1. Dec 2017 — Feb 2018 [monthly]

    Terminated NA

  2. Feb 2017 — Dec 2017 [monthly]

    Terminated NA

  3. Jan 2017 — Feb 2017 [monthly]

    Terminated NA

    First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ulthera, Inc
Data source: Merz North America, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .